These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18606571)

  • 1. Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART).
    Hebbeler AM; Propp N; Cairo C; Li H; Cummings JS; Jacobson LP; Margolick JB; Pauza CD
    Clin Immunol; 2008 Sep; 128(3):349-57. PubMed ID: 18606571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment.
    Enders PJ; Yin C; Martini F; Evans PS; Propp N; Poccia F; Pauza CD
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):21-9. PubMed ID: 12581513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
    Riedel DJ; Sajadi MM; Armstrong CL; Cummings JS; Cairo C; Redfield RR; Pauza CD
    AIDS; 2009 Sep; 23(15):1955-64. PubMed ID: 19609200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors.
    Evans PS; Enders PJ; Yin C; Ruckwardt TJ; Malkovsky M; Pauza CD
    Immunology; 2001 Sep; 104(1):19-27. PubMed ID: 11576216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy.
    Chaudhry S; Cairo C; Venturi V; Pauza CD
    AIDS; 2013 Jun; 27(10):1557-62. PubMed ID: 23525030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.
    Bordon J; Evans PS; Propp N; Davis CE; Redfield RR; Pauza CD
    J Infect Dis; 2004 Apr; 189(8):1482-6. PubMed ID: 15073686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.
    Giovannetti A; Pierdominici M; Mazzetta F; Salemi S; Marziali M; Kuonen D; Iebba F; Lusi EA; Cossarizza A; Aiuti F
    Clin Exp Immunol; 2001 Apr; 124(1):21-31. PubMed ID: 11359439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count.
    Casetti R; De Simone G; Sacchi A; Rinaldi A; Viola D; Agrati C; Bordoni V; Cimini E; Tumino N; Besi F; Martini F
    PLoS One; 2015; 10(7):e0132291. PubMed ID: 26161861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy.
    Agrati C; D'Offizi G; Narciso P; Selva C; Pucillo LP; Ippolito G; Poccia F
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1357-63. PubMed ID: 11602046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vgamma2/Vdelta2 T-cell repertoire in Macaca fascicularis: functional responses to phosphoantigen stimulation by the Vgamma2/Jgamma1.2 subset.
    Cairo C; Propp N; Hebbeler AM; Colizzi V; Pauza CD
    Immunology; 2005 Jun; 115(2):197-205. PubMed ID: 15885125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections.
    Kosub DA; Lehrman G; Milush JM; Zhou D; Chacko E; Leone A; Gordon S; Silvestri G; Else JG; Keiser P; Jain MK; Sodora DL
    J Virol; 2008 Feb; 82(3):1155-65. PubMed ID: 18045946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells.
    Miyagawa F; Tanaka Y; Yamashita S; Mikami B; Danno K; Uehara M; Minato N
    J Immunol; 2001 Dec; 167(12):6773-9. PubMed ID: 11739492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The reconstitutional profiles of peripheral blood natural killer cell, gammadelta T lymphocyte and CD(4)(+)T cell in human immunodeficiency virus infected patients during one-year antiretroviral therapy].
    Xie J; Qiu ZF; Han Y
    Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):750-3. PubMed ID: 19080202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
    Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Intra- and Inter-individual variation in T-cell subsets of HIV-infected and uninfected men participating in the LA Multi-Center AIDS Cohort Study.
    Aziz N; Jamieson BD; Quint JJ; Martinez-Maza O; Chow M; Detels R
    Medicine (Baltimore); 2019 Oct; 98(41):e17525. PubMed ID: 31593126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.
    Vrisekoop N; van Gent R; de Boer AB; Otto SA; Borleffs JC; Steingrover R; Prins JM; Kuijpers TW; Wolfs TF; Geelen SP; Vulto I; Lansdorp P; Tesselaar K; Borghans JA; Miedema F
    J Immunol; 2008 Jul; 181(2):1573-81. PubMed ID: 18606713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.